INFINITY PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q1 2012 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Infinity Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2023.
  • Infinity Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2023 was 171 %.
  • Infinity Pharmaceuticals, Inc. annual Return On Equity for 2022 was 843 %.
  • Infinity Pharmaceuticals, Inc. annual Return On Equity for 2021 was -123 %, a 139% decline from 2020.
  • Infinity Pharmaceuticals, Inc. annual Return On Equity for 2020 was 319 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 171 +470 Apr 1, 2023 Jun 30, 2023
Q1 2023 290 +465 Jan 1, 2023 Mar 31, 2023
Q4 2022 843 +966 Oct 1, 2022 Dec 31, 2022
Q3 2022 -956 -784 -456% Jul 1, 2022 Sep 30, 2022
Q2 2022 -299 +5.81 +1.91% Apr 1, 2022 Jun 30, 2022
Q1 2022 -175 +4.48K +96.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -123 -442 -139% Oct 1, 2021 Dec 31, 2021
Q3 2021 -172 -996 -121% Jul 1, 2021 Sep 30, 2021
Q2 2021 -305 +1.05K +77.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -4.65K -4.32K -1312% Jan 1, 2021 Mar 31, 2021
Q4 2020 319 +517 Oct 1, 2020 Dec 31, 2020
Q3 2020 824 +949 Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.36K -1.32K -3123% Apr 1, 2020 Jun 30, 2020
Q1 2020 -329 -298 -945% Jan 1, 2020 Mar 31, 2020
Q4 2019 -197 -175 -791% Oct 1, 2019 Dec 31, 2019
Q3 2019 -125 -105 -502% Jul 1, 2019 Sep 30, 2019
Q2 2019 -42.2 +22 +34.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 -31.5 +47.9 +60.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 -22.2 +49.4 +69% Oct 1, 2018 Dec 31, 2018
Q3 2018 -20.8 +64.8 +75.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 -64.2 +23.9 +27.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 -79.5 -79.6 -85255% Jan 1, 2018 Mar 31, 2018
Q4 2017 -71.6 -38.6 -117% Oct 1, 2017 Dec 31, 2017
Q3 2017 -85.6 -37 -75.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 -88.1 -103 -679% Apr 1, 2017 Jun 30, 2017
Q1 2017 0.09 +79.6 Jan 1, 2017 Mar 31, 2017
Q4 2016 -33 +83.6 +71.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -48.7 +45.3 +48.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 15.2 +56.7 Apr 1, 2016 Jun 30, 2016
Q1 2016 -79.5 -41.2 -107% Jan 1, 2016 Mar 31, 2016
Q4 2015 -117 -107 -1183% Oct 1, 2015 Dec 31, 2015
Q3 2015 -94 -88.7 -1682% Jul 1, 2015 Sep 30, 2015
Q2 2015 -41.5 +37.7 +47.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 -38.3 +27.3 +41.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -9.09 +42.6 +82.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -5.27 +46.4 +89.8% Jul 1, 2014 Sep 30, 2014
Q2 2014 -79.2 -45.2 -133% Apr 1, 2014 Jun 30, 2014
Q1 2014 -65.6 -29.2 -80.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 -51.7 -7.96 -18.2% Oct 1, 2013 Dec 31, 2013
Q3 2013 -51.7 -9.35 -22.1% Jul 1, 2013 Sep 30, 2013
Q2 2013 -34.1 +403 +92.2% Apr 1, 2013 Jun 30, 2013
Q1 2013 -36.4 +182 +83.3% Jan 1, 2013 Mar 31, 2013
Q4 2012 -43.7 Oct 1, 2012 Dec 31, 2012
Q3 2012 -42.4 Jul 1, 2012 Sep 30, 2012
Q2 2012 -437 Apr 1, 2012 Jun 30, 2012
Q1 2012 -218 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.